ArticlePharmaceutical patent analyst2024
Contradicting rulings of the US patent office on double patenting jeopardize the generic and biosimilar drugs.
Sarfaraz K NiaziPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it